Incannex Healthcare Limited
IXHL · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $86 | $18 | $0 | $0 |
| % Growth | 378.7% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $4 |
| Gross Profit | $86 | $18 | $0 | -$4 |
| % Margin | 100% | 100% | – | – |
| R&D Expenses | $10,747 | $19,281 | $6,309 | $3,695 |
| G&A Expenses | $12,738 | $23,978 | $6,675 | $5,114 |
| SG&A Expenses | $13,128 | $25,557 | $7,924 | $7,003 |
| Sales & Mktg Exp. | $390 | $1,579 | $1,249 | $1,889 |
| Other Operating Expenses | $0 | $154 | -$595 | -$10,702 |
| Operating Expenses | $23,875 | $44,992 | $13,638 | -$4 |
| Operating Income | -$23,789 | -$44,974 | -$13,638 | -$10,164 |
| % Margin | -27,661.6% | -250,341.7% | – | – |
| Other Income/Exp. Net | -$23,096 | $17,384 | -$35,173 | -$88 |
| Pre-Tax Income | -$46,885 | -$27,590 | -$48,811 | -$10,253 |
| Tax Expense | -$1,756 | $45 | $0 | $0 |
| Net Income | -$46,885 | -$27,635 | -$48,811 | -$10,253 |
| % Margin | -54,517.4% | -153,825% | – | – |
| EPS | -1.36 | -1.14 | -3.17 | -0.035 |
| % Growth | -19.3% | 64% | -9,061.8% | – |
| EPS Diluted | -1.36 | -1.14 | -3.17 | -0.035 |
| Weighted Avg Shares Out | 34,454 | 16,164 | 15,385 | 297,792 |
| Weighted Avg Shares Out Dil | 34,454 | 16,164 | 15,385 | 297,789 |
| Supplemental Information | – | – | – | – |
| Interest Income | $62 | $308 | $241 | $4 |
| Interest Expense | $303 | $0 | $0 | $0 |
| Depreciation & Amortization | $246 | $154 | $88 | $0 |
| EBITDA | -$48,092 | -$27,702 | -$13,550 | -$10,164 |
| % Margin | -55,920.9% | -154,200% | – | – |